Journal of Dali University ›› 2021, Vol. 6 ›› Issue (10): 1-.DOI: 10. 3969/j. issn. 2096-2266. 2021. 10. 001

    Next Articles

Pharmacokinetic Characteristics of Gualou-Xiebai Intragastric Floating Pellets in Rats by LC-MS / MS

Yan Haiyan Sun Dekao Zou Chuncai   

  1. 1. School of Pharmacy Wannan Medical College Wuhu Anhui 241002 China 2. Jiangsu Kaiyuan Pharmaceutical Co. Ltd. Nanjing 222000 China

  • Received:2020-12-29 Revised:2021-04-13 Online:2021-10-15 Published:2021-12-11

Abstract:

 Objective To study the plasma concentration and pharmacokinetics of 329-dibenzoyl-karounitriol 329-DK in Gualou-Xiebai intragastric floating pellets hereinafter referred to as "Gualou-Xiebai pellets" at different time points in rats by liquid chromatography tandem mass spectrometryLC-MS/MS. Methods 12 SPF SD male rats were randomly divided into Gualou- Xiebai pellets group2.0 g/kg and Gualou-Xiebai extracts group1.4 g/ kg), the blood samples were taken from the orbit 0 h before administration and 0.5 1 2 3 4 6 8 10 12 24 36 48 h after administration in Gualou-Xiebai pellets group the blood samples were taken from the orbit 0 h before administration and 51030 min 1 1.5 2 3 4 6 and 8 h after administration in the Gualou-Xiebai extracts group and the pharmacokinetic parameters were calculated. Results Compared with the Gualou-Xiebai extracts group the 329-DK peak time AUC and t1/2 in the Gualou-Xiebai pellet group were significantly prolonged P<0.05), and MRT was significantly increased P<0.05), CLz/F Cmax was significantly reduced P<0.05. Conclusion The release rate of 329-DK in Gualou-Xiebai pellets was stable in rats without sudden release and rapid release and the metabolic time was prolonged. Gualou-Xiebai pellets have sustained-release effect.

Key words:  LC-MS/MS Gualou-Xiebai intragastric floating pellets 3, 29-dibenzoyl-karounitriol pharmacokinetics

CLC Number: